{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:14:04Z","timestamp":1759936444967,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["JIP\/Res\/Intramural\/Phs1\/2018-19\/5\/37 dt 16 Nov 2018","JIP\/Res\/Intramural\/Phs 2\/2019-20\/10\/74 dt 13 Feb 2020","JIP\/Res\/Intramural\/Phs2\/2020-21\/2\/7 dt 23 Dec 2020."],"award-info":[{"award-number":["JIP\/Res\/Intramural\/Phs1\/2018-19\/5\/37 dt 16 Nov 2018","JIP\/Res\/Intramural\/Phs 2\/2019-20\/10\/74 dt 13 Feb 2020","JIP\/Res\/Intramural\/Phs2\/2020-21\/2\/7 dt 23 Dec 2020."]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00774-023-01444-9","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:01:52Z","timestamp":1688637712000},"page":"682-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Negative impact on bone homeostasis in postmenopausal women with non-metastatic breast cancer during cytotoxic chemotherapy"],"prefix":"10.1007","volume":"41","author":[{"given":"Yadav","family":"Nisha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-2525","authenticated-orcid":false,"given":"Biswajit","family":"Dubashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachariah","family":"Bobby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya Prakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Bhaskar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"L","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrrheum.2013.36","volume":"9","author":"RE Coleman","year":"2013","unstructured":"Coleman RE, Rathbone E, Brown JE (2013) Management of cancer treatment-induced bone loss. Nat Rev Rheumatol 9:365\u2013374. https:\/\/doi.org\/10.1038\/nrrheum.2013.36","journal-title":"Nat Rev Rheumatol"},{"key":"1444_CR2","first-page":"39","volume":"2","author":"N Khachidze","year":"2017","unstructured":"Khachidze N, Giorgadze E, Tsagareli M (2017) adjuvant (hormonal) therapy as a cause of bone loss in patients with breast cancer (review of literature). Georgian Med News 2:39\u201342","journal-title":"Georgian Med News"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186\u20131194. https:\/\/doi.org\/10.1172\/JCI28550","journal-title":"J Clin Invest"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/0284186X.2010.533190","volume":"50","author":"M Ewertz","year":"2011","unstructured":"Ewertz M, Jensen AB (2011) Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 50:187\u2013193. https:\/\/doi.org\/10.3109\/0284186X.2010.533190","journal-title":"Acta Oncol"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3810\/pgm.1998.10.447","volume":"104","author":"CJ Rosen","year":"1998","unstructured":"Rosen CJ, Tenenhouse A (1998) Biochemical markers of bone turnover. A look at laboratory tests that reflect bone status. Postgrad Med 104:101\u2013102. https:\/\/doi.org\/10.3810\/pgm.1998.10.447","journal-title":"Postgrad Med"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s001980070002","volume":"11","author":"PD Delmas","year":"2000","unstructured":"Delmas PD, Eastell R, Garnero P et al (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11:S2-17. https:\/\/doi.org\/10.1007\/s001980070002","journal-title":"Osteoporos Int"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbcan.2014.09.001","volume":"1846","author":"K Jung","year":"2014","unstructured":"Jung K, Lein M (2014) Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta 1846:425\u2013438. https:\/\/doi.org\/10.1016\/j.bbcan.2014.09.001","journal-title":"Biochim Biophys Acta"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jbmr.3355","volume":"33","author":"DC Bauer","year":"2018","unstructured":"Bauer DC, Black DM, Bouxsein ML et al (2018) Treatment-related changes in bone turnover and fracture risk reduction in clinical trials of anti-resorptive drugs: a meta-regression. J Bone Miner Res 33:634\u2013642. https:\/\/doi.org\/10.1002\/jbmr.3355","journal-title":"J Bone Miner Res"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/EJE-17-0585","volume":"178","author":"R Eastell","year":"2018","unstructured":"Eastell R, Pigott T, Gossiel F et al (2018) DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful? Eur J Endocrinol 178:R19\u2013R31. https:\/\/doi.org\/10.1530\/EJE-17-0585","journal-title":"Eur J Endocrinol"},{"key":"1444_CR10","first-page":"25","volume":"24","author":"MEH Kailaj\u00e4rvi","year":"2004","unstructured":"Kailaj\u00e4rvi MEH, Salminen EK, Paija OMM et al (2004) Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy. Anticancer Res 24:25","journal-title":"Anticancer Res"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2014.12.028","volume":"402","author":"DR Oostra","year":"2015","unstructured":"Oostra DR, Lustberg MB, Reinbolt RE et al (2015) Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Mol Cell Endocrinol 402:51\u201356. https:\/\/doi.org\/10.1016\/j.mce.2014.12.028","journal-title":"Mol Cell Endocrinol"},{"key":"1444_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-3803-0","author":"LM Rodr\u00edguez-Rodr\u00edguez","year":"2005","unstructured":"Rodr\u00edguez-Rodr\u00edguez LM, Rodr\u00edguez-Rodr\u00edguez EM, Oramas-Rodr\u00edguez JM et al (2005) Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-005-3803-0","journal-title":"Breast Cancer Res Treat"},{"key":"1444_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126053","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen Y, Xu G, Yang F (2015) Effect of neoadjuvant chemotherapy on the serum levels of bone turnover markers in women with early-stage breast cancer. PLoS ONE 10:e0126053. https:\/\/doi.org\/10.1371\/journal.pone.0126053","journal-title":"PLoS ONE"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-012-2084-7","volume":"134","author":"W Jacot","year":"2012","unstructured":"Jacot W, Pouderoux S, Thezenas S et al (2012) Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat 134:709\u2013717. https:\/\/doi.org\/10.1007\/s10549-012-2084-7","journal-title":"Breast Cancer Res Treat"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-l","volume":"17","author":"SC Manolagas","year":"1995","unstructured":"Manolagas SC (1995) Role of cytokines in bone resorption. Bone 17:63S-67S. https:\/\/doi.org\/10.1016\/8756-3282(95)00180-l","journal-title":"Bone"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.yexcr.2007.09.021","volume":"314","author":"M Kinder","year":"2008","unstructured":"Kinder M, Chislock E, Bussard KM et al (2008) Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res 314:173\u2013183. https:\/\/doi.org\/10.1016\/j.yexcr.2007.09.021","journal-title":"Exp Cell Res"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2217\/14750708.2.5.787","volume":"2","author":"M Abdollahi","year":"2005","unstructured":"Abdollahi M, Larijani B, Rahimi R, Salari P (2005) Role of oxidative stress in osteoporosis. Therapy 2:787\u2013796. https:\/\/doi.org\/10.2217\/14750708.2.5.787","journal-title":"Therapy"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","volume":"7","author":"P Hadji","year":"2017","unstructured":"Hadji P, Aapro MS, Body J-J et al (2017) Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG. J Bone Oncol 7:1\u201312. https:\/\/doi.org\/10.1016\/j.jbo.2017.03.001","journal-title":"J Bone Oncol"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mjafi.2015.11.007","volume":"72","author":"T Mukherjee","year":"2016","unstructured":"Mukherjee T (2016) Interpretation of ER and Her2neu hormonal receptor in breast cancer. Med J Armed Forces India 72:99. https:\/\/doi.org\/10.1016\/j.mjafi.2015.11.007","journal-title":"Med J Armed Forces India"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.5858\/arpa.2013-0566-CP","volume":"138","author":"PL Fitzgibbons","year":"2014","unstructured":"Fitzgibbons PL, Dillon DA, Alsabeh R et al (2014) Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. Arch Pathol Lab Med 138:595\u2013601. https:\/\/doi.org\/10.5858\/arpa.2013-0566-CP","journal-title":"Arch Pathol Lab Med"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-h","volume":"186","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407\u2013421. https:\/\/doi.org\/10.1016\/0076-6879(90)86134-h","journal-title":"Methods Enzymol"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","volume":"135","author":"T Yoshioka","year":"1979","unstructured":"Yoshioka T, Kawada K, Shimada T, Mori M (1979) Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 135:372\u2013376. https:\/\/doi.org\/10.1016\/0002-9378(79)90708-7","journal-title":"Am J Obstet Gynecol"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IFF Benzie","year":"1996","unstructured":"Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem 239:70\u201376. https:\/\/doi.org\/10.1006\/abio.1996.0292","journal-title":"Anal Biochem"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/bcr2920","volume":"13","author":"A Vrieling","year":"2011","unstructured":"Vrieling A, Hein R, Abbas S et al (2011) Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 13:R74. https:\/\/doi.org\/10.1186\/bcr2920","journal-title":"Breast Cancer Res"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/ijms21145169","volume":"21","author":"H Kitaura","year":"2020","unstructured":"Kitaura H, Marahleh A, Ohori F et al (2020) Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci 21:5169. https:\/\/doi.org\/10.3390\/ijms21145169","journal-title":"Int J Mol Sci"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"KT Steeve","year":"2004","unstructured":"Steeve KT, Marc P, Sandrine T et al (2004) IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49\u201360. https:\/\/doi.org\/10.1016\/j.cytogfr.2003.10.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"1444_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00774-015-0679-x","volume":"34","author":"C Fan","year":"2016","unstructured":"Fan C, Georgiou KR, McKinnon RA et al (2016) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Miner Metab 34:277\u2013290. https:\/\/doi.org\/10.1007\/s00774-015-0679-x","journal-title":"J Bone Miner Metab"},{"key":"1444_CR28","doi-asserted-by":"publisher","first-page":"41411","DOI":"10.1038\/srep41411","volume":"7","author":"W Feng","year":"2017","unstructured":"Feng W, Liu H, Luo T et al (2017) Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways. Sci Rep 7:41411. https:\/\/doi.org\/10.1038\/srep41411","journal-title":"Sci Rep"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med 191:275\u2013286. https:\/\/doi.org\/10.1084\/jem.191.2.275","journal-title":"J Exp Med"},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopha.2018.03.080","volume":"102","author":"L Zha","year":"2018","unstructured":"Zha L, He L, Liang Y et al (2018) TNF-\u03b1 contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. Biomed Pharmacother 102:369\u2013374. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.080","journal-title":"Biomed Pharmacother"},{"key":"1444_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1742-7843.2010.00621.x","volume":"108","author":"S Numazawa","year":"2011","unstructured":"Numazawa S, Sugihara K, Miyake S et al (2011) Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice. Basic Clin Pharmacol Toxicol 108:40\u201345. https:\/\/doi.org\/10.1111\/j.1742-7843.2010.00621.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","volume":"14","author":"V Domazetovic","year":"2017","unstructured":"Domazetovic V, Marcucci G, Iantomasi T et al (2017) Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab 14:209\u2013216. https:\/\/doi.org\/10.11138\/ccmbm\/2017.14.1.209","journal-title":"Clin Cases Miner Bone Metab"},{"key":"1444_CR33","doi-asserted-by":"publisher","first-page":"17497","DOI":"10.1074\/jbc.M409332200","volume":"280","author":"X Bai","year":"2005","unstructured":"Bai X, Lu D, Liu A et al (2005) Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280:17497\u201317506. https:\/\/doi.org\/10.1074\/jbc.M409332200","journal-title":"J Biol Chem"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1359\/jbmr.080616","volume":"23","author":"PH Anderson","year":"2008","unstructured":"Anderson PH, Sawyer RK, Moore AJ et al (2008) Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789\u20131797. https:\/\/doi.org\/10.1359\/jbmr.080616","journal-title":"J Bone Miner Res"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1359\/jbmr.1997.12.5.734","volume":"12","author":"H Kaji","year":"1997","unstructured":"Kaji H, Sugimoto T, Kanatani M et al (1997) Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. J Bone Miner Res 12:734\u2013741. https:\/\/doi.org\/10.1359\/jbmr.1997.12.5.734","journal-title":"J Bone Miner Res"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"44667","DOI":"10.1074\/jbc.M300213200","volume":"278","author":"A Takuma","year":"2003","unstructured":"Takuma A, Kaneda T, Sato T et al (2003) Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. J Biol Chem 278:44667\u201344674. https:\/\/doi.org\/10.1074\/jbc.M300213200","journal-title":"J Biol Chem"},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/BF02968254","volume":"29","author":"YH Kim","year":"2006","unstructured":"Kim YH, Jun J-H, Woo KM et al (2006) Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of beta3 integrin expression. Arch Pharm Res 29:691\u2013698. https:\/\/doi.org\/10.1007\/BF02968254","journal-title":"Arch Pharm Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-023-01444-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-023-01444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T05:08:02Z","timestamp":1695100082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-023-01444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s00774-023-01444-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yadav Nisha, Biswajit Dubashi, Zachariah Bobby, Jaya Prakash Sahoo, Smita Kayal, Ramesh Ananthakrishnan, Vijay Bhaskar Reddy, Charles L, and Prasanth Ganesan declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Jawaharlal Institute of Postgraduate Medical Education & Research (IEC No.: JIP\/IEC\/2018\/0176), date: 10\/07\/2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}